Has Shamar Young, MD received payments from drug or device companies?

Yes. Drug and device makers reported $284,922 in general payments to Shamar Young, MD across 302 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shamar Young, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shamar Young, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shamar Young, MD

Vascular & Interventional Radiology · Tucson, AZNPI 1528389574

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $174,900 of the $284,922 with a category attached, or 61.4%. Boston Scientific accounts for 79.5% of it on its own, with 15 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$284,922in general payments, 2019–2025

Across 302 payments — averaging $943.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$226K
Galil Medical Inc.$28K
Siemens Medical Solutions USA, Inc.$13K
Biocompatibles, Inc.$13K
Trisalus Life Sciences, Inc.$1K
Terumo Medical Corporation$1K
plus $3K from 10 others

$93,175in research payments, 2019–2025

Across 34 payments — averaging $2740.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

ABK Biomedical USA, Inc.$83K
Boston Scientific$8K
Biocompatibles UK Ltd$3K

What the payments were for

Consulting fees$83,53829%
Speaking & faculty fees$174,90061%
Grants$8000%
Travel & lodging$13,9495%
Food & beverage$11,7354%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	221	$226,488
Galil Medical Inc.	17	$27,590
Siemens Medical Solutions USA, Inc.	3	$13,350
Biocompatibles, Inc.	13	$12,508
Trisalus Life Sciences, Inc.	3	$1,276
Terumo Medical Corporation	3	$1,150
Penumbra, Inc.	13	$990
Inari Medical, Inc.	11	$505
ABK Biomedical USA, Inc.	5	$311
Sirtex Medical Inc	3	$180
Argon Medical Devices, Inc.	2	$151
Angiodynamics, Inc.	1	$144
BTG International Canada Inc.	1	$125
W. L. Gore & Associates, Inc.	3	$103
Medtronic	2	$38
Bard Peripheral Vascular, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TheraSphere Y90 Glass Microspheres 10 GBq$88,074
GENERAL - IO ABLATION$29,486
GENERAL - THERAPIES$26,305
ICEFX$19,769
VISUAL-ICE$16,181
THERASPHERE-BIO$12,374
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$10,900
GENERAL EMBOLICS$9,881
MicroThermX Microwave Ablation System$9,600
GENERAL PAIN MANAGEMENT$7,340
THERASPHERE$6,810
GENERAL VASCULAR INTERVENTION$4,757
TheraSphere Administration Set$4,200
TRINAV INFUSION SYSTEM$1,250
Navicross$800
Azur CX Detachable$350
OBSIDIO$302
Indigo System$292
AMS$272
RUBY Coil$247

How this compares

$284,922 in reported general payments places this provider in the 95th percentile of 80 vascular & interventional radiology providers in Arizona.

See all vascular & interventional radiology providers in Arizona →

Medicare billing

Part B allowed, 2024

$92,744

Medicare patients

285

Services billed

1,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Tucson

Gregory WoodheadTucson$33K
Samuel OatsTucson$13K
Daniel GoldbergTucson$11K
Christopher HarmsTucson$8K
Ilaria Vittoria de MartiniTucson$6K
Jack HannallahTucson$6K
Lucas StruyckenTucson$3K
Jose EcheverriTucson$2K
Artyom AbramyanTucson$2K
Paola DevisTucson$1K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →